{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:52:07Z","timestamp":1777873927038,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2415200"],"award-info":[{"award-number":["2023YFC2415200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20220484111"],"award-info":[{"award-number":["20220484111"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["QNJJ2022016"],"award-info":[{"award-number":["QNJJ2022016"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["LHJJ2023003"],"award-info":[{"award-number":["LHJJ2023003"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["PY202335"],"award-info":[{"award-number":["PY202335"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["JQ24048"],"award-info":[{"award-number":["JQ24048"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejso.2026.111455","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:59:29Z","timestamp":1769713169000},"page":"111455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Appropriate number of retrieved lymph nodes is sufficient for node-negative patients with gastric cancer"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3781-2742","authenticated-orcid":false,"given":"Bentuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinkui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2096-6526","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111455_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.111455_bib2","series-title":"American Joint Committee on cancer. Cancer staging manual","year":"2017"},{"key":"10.1016\/j.ejso.2026.111455_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN Clinical Practice Guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2026.111455_bib4","first-page":"127","article-title":"The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer","volume":"44","author":"Wang","year":"2023","journal-title":"Cancer Commun (Lond) 2024"},{"key":"10.1016\/j.ejso.2026.111455_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1245\/s10434-015-4578-0","article-title":"Incorporation of N0 stage with insufficient numbers of lymph nodes into N1 stage in the seventh edition of the TNM classification improves prediction of prognosis in gastric cancer: results of a single-institution Study of 1258 Chinese patients","volume":"23","author":"Li","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ejso.2015.03.227","article-title":"Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?","volume":"41","author":"Biondi","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/603194","article-title":"The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer","volume":"2014","author":"Song","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejso.2026.111455_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejso.2011.01.013","article-title":"Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection","volume":"37","author":"Biffi","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1245\/s10434-016-5513-8","article-title":"Increasing the number of examined lymph nodes is a prerequisite for improvement in the accurate evaluation of overall survival of Node-Negative gastric cancer patients","volume":"24","author":"Deng","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.21147\/j.issn.1000-9604.2018.05.01","article-title":"Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system","volume":"30","author":"Deng","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.ejso.2026.111455_bib11","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1111\/cas.15003","article-title":"Exceeding 30 ELNs is strongly recommended for pT3-4N0 patients with gastric cancer: a multicenter study of survival, recurrence, and prediction model","volume":"112","author":"Zhao","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2026.111455_bib12","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.111455_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","volume":"23","author":"Kang","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(18)31257-1","article-title":"Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial","volume":"392","author":"Shitara","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.111455_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JS9.0000000000000774","article-title":"Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study","volume":"110","author":"Deng","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2026.111455_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.annonc.2024.10.829","volume":"36","author":"Lordick","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib18","first-page":"1","volume":"26","year":"2023","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2026.111455_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.21147\/j.issn.1000-9604.2017.04.05","article-title":"Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary","volume":"29","author":"T\u00f3th","year":"2017","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.ejso.2026.111455_bib20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1155\/2008\/761821","article-title":"Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence","volume":"22","author":"Deng","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.ejso.2026.111455_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00000658-200009000-00008","article-title":"Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients","volume":"232","author":"Karpeh","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111455_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.surg.2014.03.020","volume":"156","author":"Deng","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2026.111455_bib23","article-title":"Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2026.111455_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/SLA.0b013e3181e4585e","article-title":"A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients","volume":"252","author":"Baiocchi","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111455_bib25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2013.08.027","article-title":"Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes","volume":"40","author":"Martinez-Ramos","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jjco\/hyv159","article-title":"Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy","volume":"46","author":"He","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111455_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0000000000003883","article-title":"Surgeon quality control and standardization of D2 lymphadenectomy for gastric cancer: a prospective multicenter observational study (KLASS-02-QC)","volume":"273","author":"Han","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111455_bib28","article-title":"Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial","volume":"2","author":"Xie","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ejso.2026.111455_bib29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00464-020-08070-w","article-title":"Application of clockwise modularized laparoscopic lymphadenectomy in the suprapancreatic area, a propensity score matching study and comparison with open gastrectomy","volume":"35","author":"Yang","year":"2021","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2026.111455_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1840","article-title":"Assessment of lymph node metastasis in patients with gastric cancer to identify those suitable for middle segmental gastrectomy","volume":"4","author":"Khalayleh","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2026.111455_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ejso.2026.111455_bib32","article-title":"Exhausted CD8+T cells in the tumor immune microenvironment: new pathways to therapy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejso.2026.111455_bib33","article-title":"Tumor-draining lymph nodes: at the crossroads of metastasis and immunity","volume":"6","author":"du","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ejso.2026.111455_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","article-title":"The tumor-draining lymph node as a reservoir for systemic immune surveillance","volume":"10","author":"Delclaux","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ejso.2026.111455_bib35","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00262-021-02934-3","article-title":"Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used","volume":"70","author":"Fear","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ejso.2026.111455_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-025-04168-z","article-title":"Impact of lymph node dissection on survival after neoadjuvant immunochemotherapy for esophageal squamous cell cancer: a double-center real-world retrospective study","volume":"74","author":"Huang","year":"2025","journal-title":"Cancer Immunol Immunother"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:33:11Z","timestamp":1777573991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326000740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0748798326000740"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111455","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate number of retrieved lymph nodes is sufficient for node-negative patients with gastric cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111455"}}